FeesSafety
Pluang+

Healthcare equipment undervalued; pharma/biotech overvalued; Invesco PJP ETF outperforms sector benchmark XLV.

Market News
17 Nov 2026, 15:10 WIB
Seeking Alpha
View Source
Neutral
Healthcare equipment undervalued; pharma/biotech overvalued; Invesco PJP ETF outperforms sector benchmark XLV.

The healthcare equipment sector is currently undervalued compared to historical averages, while the pharmaceutical and biotechnology sectors are significantly overvalued. The Invesco Pharmaceuticals ETF (PJP) provides diversified pharmaceutical exposure suitable for both long-term and tactical investment strategies. Since its inception, PJP has outperformed the sector benchmark XLV and also outperformed it over the past 12 months, although it lagged behind XLV from July 2015 to July 2025. This analysis helps investors identify value and momentum opportunities within healthcare ETFs and stocks.

The Health Care Select Sector SPDR Fund (XLV) trades at USD 186.03 on Pluang as of Nov 17, 2026 20:21 WIB, showing a 0.99% decline in one day. This ETF holds a market cap of $50.57 billion and sees a typical hold time of 99 days among Pluang investors. The article's focus on healthcare sector valuations aligns with XLV's active trading volume of 9,651,914 shares and a strong buy sentiment at 70% on Pluang.

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App